Research into the gut microbiota has revealed that gut microorganisms can impact cholesterol metabolism and homeostasis, providing physicians with an additional therapeutic target to help improve cholesterol management in their patients. Join Rebecca Edwards for an exploration into the cholesterol metabolism and excretion pathways impacted upon by the microbial community in the gut. Rebecca will also be discussing specific strains of probiotic microorganisms which have been shown to improve the management of cholesterol, including both LDL and small LDL levels, positively impact the lipoprotein profile (including ApoB), and improve the antioxidant capacity of cholesterol particles.